Variant report
Variant | esv3451417 |
---|---|
Chromosome Location | chr7:150192334-150195371 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs562217595 | chr7:150192336-150192337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs531453069 | chr7:150192356-150192357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs201080687 | chr7:150192359-150192360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547861623 | chr7:150192376-150192377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568076131 | chr7:150192393-150192394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533842036 | chr7:150192399-150192400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs202045503 | chr7:150192402-150192403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547710070 | chr7:150192403-150192404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200180815 | chr7:150192408-150192409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200794707 | chr7:150192416-150192417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs180764736 | chr7:150192421-150192422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539593954 | chr7:150192438-150192439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556413996 | chr7:150192471-150192472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs184378526 | chr7:150192483-150192484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576329274 | chr7:150192497-150192498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538368386 | chr7:150192506-150192507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554665524 | chr7:150192509-150192510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574819650 | chr7:150192540-150192541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540279756 | chr7:150192543-150192544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543719191 | chr7:150192547-150192548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560369598 | chr7:150192570-150192571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs373887768 | chr7:150192580-150192581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545953527 | chr7:150192609-150192610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562777326 | chr7:150192610-150192611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531285030 | chr7:150192615-150192616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541955619 | chr7:150192640-150192641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565492437 | chr7:150192654-150192655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370887327 | chr7:150192676-150192677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552440402 | chr7:150192693-150192694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547418708 | chr7:150192699-150192700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527547877 | chr7:150192706-150192707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570728927 | chr7:150192712-150192713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533279040 | chr7:150192736-150192737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs116529357 | chr7:150192737-150192738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188423187 | chr7:150192755-150192756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537946539 | chr7:150192767-150192768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs571763544 | chr7:150192853-150192854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs146675246 | chr7:150192890-150192891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs77763751 | chr7:150192950-150192951 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553767382 | chr7:150192979-150192980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs73729151 | chr7:150193051-150193052 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs13438625 | chr7:150193057-150193058 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs556336374 | chr7:150193076-150193077 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576616962 | chr7:150193078-150193079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs72280706 | chr7:150193101-150193102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538690088 | chr7:150193128-150193129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542067175 | chr7:150193136-150193137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs66517613 | chr7:150193143-150193144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181251674 | chr7:150193150-150193151 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs111914604 | chr7:150193164-150193165 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Schizophrenia | 17646849 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Autism | 20808228 | CNVD |
Breast cancer | 21509527 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Heart disease | 21282601 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Lobular carcinoma | 20920651 | CNVD |
Long-qt syndrome | 20920651 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Long-qt syndrome | 17576883 | CNVD |
Bradycardia syndrome | 17576883 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Ependymoma | 20639864 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:150180400-150199000 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
2 | chr7:150185000-150193200 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
3 | chr7:150186200-150192800 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
4 | chr7:150187400-150192800 | Weak transcription | Primary T helper naive cells from peripheral blood | blood |
5 | chr7:150192200-150197200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
6 | chr7:150192800-150193000 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
7 | chr7:150192800-150193600 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
8 | chr7:150193000-150199400 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
9 | chr7:150193200-150193600 | Enhancers | Primary T killer memory cells from peripheral blood | blood |
10 | chr7:150193200-150193800 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
11 | chr7:150193200-150194000 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
12 | chr7:150193400-150193800 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
13 | chr7:150193400-150193800 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
14 | chr7:150193400-150193800 | Enhancers | Primary T helper cells fromperipheralblood | blood |
15 | chr7:150193400-150193800 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
16 | chr7:150193400-150194000 | Enhancers | Primary T cells fromperipheralblood | blood |
17 | chr7:150193600-150193800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr7:150193600-150199400 | Weak transcription | Primary T helper naive cells from peripheral blood | blood |
19 | chr7:150193800-150199000 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
20 | chr7:150193800-150199400 | Weak transcription | Primary T helper 17 cells PMA-I stimulated | -- |
21 | chr7:150194000-150199000 | Weak transcription | Primary T cells fromperipheralblood | blood |